Pharmafile Logo
Pharmafocus logo
Advanced Search
Esbriet image

InterMune scores in lung trial

February 26, 2014
Research and Development, Sales and Marketing Esbriet, FDA, IPF, InterMune, fvc, lung

InterMune has taken another step on its lengthy road to get the US regulator to approve its drug Esbriet for …

News
BMS image

BMS/AZ fat disorder drug gains FDA approval

February 26, 2014
Research and Development, Sales and Marketing AstraZeneca, BMS, FDA, hep C, metreleptin, myalept

Bristol-Myers Squibb and partner AstraZeneca have been granted FDA approval for a new drug to treat rare and potentially fatal …

News
rupert_gowrley

Bupa hires MHP Health head

February 26, 2014
Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing BUPA, gowrley, mhp health

Rupert Gowrley is leaving his role as joint head at MHP Health in order to start with Bupa as its …

Appointment
lilly image

Lilly’s diabetes drug matches Victoza

February 26, 2014
Research and Development, Sales and Marketing EMA, FDA, Victoza, dulaglutide, lilly

Eli Lilly’s once-weekly diabetes candidate dulaglutide has matched Novo Nordisk’s established once-daily Victoza (liraglutide) when it comes to lowering blood …

News

FDA: India needs more inspectors

February 25, 2014
Manufacturing and Production FDA, India, generics, hamburg

The Food and Drug Administration is to put more inspectors on the ground in India, following a visit there by …

News

Samsung focussing increasingly on health tech

February 25, 2014
Medical Communications, Sales and Marketing Apple, Samsung, digital, health tech, innovation lab, smartwatch

Samsung has partnered with a US university to create a digital health innovation laboratory whilst also unveiling some new health-tracking …

News
jean-christophe_tellier

UCB names next chief executive

February 25, 2014
Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing UCB, tellier

Biopharma firm UCB has confirmed its current chief executive Roch Doliveux is to be replaced by Jean-Christophe Tellier. Tellier (pictured) …

Appointment
Yervoy image

NICE restricts Yervoy use

February 25, 2014
Sales and Marketing BMS, Cancer, NHS, NICE, Yervoy, melanoma

Bristol-Myers Squibb has been dealt a blow by NICE after the UK cost watchdog recommended that the use of skin …

News
FDA image

FDA given $20 million for generic testing

February 24, 2014
Manufacturing and Production, Sales and Marketing ADHD, FDA, generics, hamburg

The FDA has been given $20 million to help it assess generic treatments, a group of drugs that makes up …

News

Europe poised for generic Symbicort

February 24, 2014
Manufacturing and Production, Sales and Marketing AstraZeneca, CHMP, COPD, Symbicort, Teva, breo, generics

The CHMP has given Teva Pharmaceutical Industries a lift by recommending that its generic version of AstraZeneca’s lung drug Symbicort …

News
GSK image

CHMP breathes new life into GSK, Teva and Novartis

February 24, 2014
Research and Development, Sales and Marketing CHMP, COPD, EMA, GSK, Gilead, Teva, asthma, onoro

The CHMP has given its backing to a number of new treatments for respiratory diseases, which include two from London-based …

News
Lisa image

A treatment room view

February 24, 2014
Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing CDF, Cancer, NHS, NICE, Roche, avastin, hinsely

A little more than a year ago, Lisa Hinsley’s prospects were not good. The mother of three had been diagnosed …

Feature

New VP of Operations for Exco InTouch

February 24, 2014
Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Exco InTouch, burke

Healthcare data services firm Exco InTouch has appointed Laurence Burke as its vice president of Operations. Burke takes over 20 …

Appointment
Gilead image

‘Compassionate’ use of hep C combo

February 24, 2014
Research and Development, Sales and Marketing CHMP, EMA, Gilead, hep C, ledipasvir, sovaldi

A key adviser to the European regulator has said that Gilead Sciences’ fixed-dose combination of Sovaldi and ledipasvir can be …

News
lilly_outside_plaque_1

Lilly drug improves lung cancer survival

February 21, 2014
Research and Development, Sales and Marketing NSCLC, lilly, necitumumab, ramucirumab

News
screen_shot_2014-02-21_at_10

New head of Biosimilars for Merck KGaA

February 21, 2014
Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Merck KGaA, biosimilars, simon sturge

Simon Sturge is joining Merck KGaA from Boehringer Ingelheim in order to head its Biosimilars unit. In his new role …

Appointment
lundbeck_wall_0

Pharma sponsored ‘weekend family gathering’

February 21, 2014
Medical Communications, Sales and Marketing ABPI, Facebook, PMCPA

News
gsk image

GSK/Theravance lung drug bags CHMP approval

February 21, 2014
Sales and Marketing CHMP, COPD, GSK, Theravance, anoro

The CHMP has given its backing to GlaxoSmithKline and partner Theravance’s new chronic obstructive pulmonary disease medicine Anoro. The treatment …

News
allison_jeynes-ellis

Avillion appoints pharma veteran as chief executive

February 21, 2014
Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Allison Jeynes-Ellis, Avillion

Drug development firm Avillion has appointed Dr Allison Jeynes-Ellis to be its chief executive. By stepping into the role Jeynes-Ellis …

Appointment
Novartis image

Skin cancer pill shows ‘significant’ response

February 20, 2014
Research and Development, Sales and Marketing LDE225, Novartis, bolt, skin cancer, smo

Novartis is celebrating after its investigational pill targeting the most common form of skin cancer met its primary endpoint in …

News
The Gateway to Local Adoption Series

Latest content

Thermo Fisher opens new distribution centre in Ireland

March 12, 2026

Altimetrik appoints Dhirendra Nath as Chief Human Resources Officer

March 12, 2026

Kindeva appoints Mike Cowhig as Chief Legal Officer

March 11, 2026

DiaMedica gets regulatory clearance from Health Canada for phase 2 preeclampsia study

March 11, 2026

Abselion establishes a US subsidiary in Massachusetts 

March 10, 2026